{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:51:50Z","timestamp":1792709510586,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007465","name":"UiT The Arctic University of Norway","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007465","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To examine circulating calprotectin and deoxyribonuclease (DNase) serum levels during hospitalization in COVID-19 patients, their continuity post-discharge and dynamics in relation to disease severity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Serum levels were measured in samples collected from 252 COVID-19 patients during hospitalization (admission, days 3\u20135 and 7\u201310), at 3 months and after 1 year, and related to admission to intensive care unit (ICU) or high dependency unit (HDU), and 60-day total mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>During hospitalization, calprotectin and DNase levels were significantly elevated compared to healthy controls (HC). Calprotectin was increased in ICU\/HDU patients compared to those at wards during hospitalization and in non-survivors compared to survivors during prolonged hospitalization. High calprotectin levels at admission were associated with male sex, PaO2\/FiO2 ratio and national COVID-19 wave 2 and 3 compared to wave 1. High admission levels of both calprotectin and ferritin were associated with an approximately twofold higher odds ratio for ICU\/HDU admission than either marker alone. DNase was lower at admission in non-survivors compared to survivors. Post-discharge, DNase but not calprotectin levels remained elevated extending to 1-year follow-up compared to HC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>COVID\u201119 non\u2011survivors showed persistently higher calprotectin levels during prolonged hospitalization, and elevated admission calprotectin was associated with later pandemic waves and poorer oxygenation. Incorporating calprotectin with ferritin improved prediction of ICU\/HDU admission. DNase levels were lower at admission in non\u2011survivors, while overall DNase remained elevated from hospitalization through 1\u2011year follow\u2011up compared with HC, suggesting a possible role in long\u2011term COVID\u201119\u2013related immune alterations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-026-12939-x","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T15:44:28Z","timestamp":1772466268000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Serial blood serum measurements of calprotectin and deoxyribonuclease in COVID-19 patients during hospitalization and recovery until one year: a prospective, multicenter, observational study"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1319-6511","authenticated-orcid":false,"given":"Anders Benjamin","family":"Kildal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thor","family":"Ueland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Reza","family":"Mirlashari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise Sofie","family":"Nissen-Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beathe Kiland","family":"Granerud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Ma","family":"Dyrhol-Riise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian","family":"Tonby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksander Rygh","family":"Holten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Heggelund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl Erik","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Tveita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simen","family":"B\u00f8e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magne Kristoffer","family":"Fagerhol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geir","family":"Hetland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Cato","family":"Holter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of Norwegian SARS-CoV-2 study group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,2]]},"reference":[{"key":"12939_CR1","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ejim.2023.11.001","volume":"122","author":"NK Gatselis","year":"2024","unstructured":"Gatselis NK, Lyberopoulou A, Lygoura V, Giannoulis G, Samakidou A, Vaiou A, et al. Calprotectin serum levels on admission and during follow-up predict severity and outcome of patients with COVID-19: A prospective study. Eur J Intern Med. 2024;122:78\u201385. https:\/\/doi.org\/10.1016\/j.ejim.2023.11.001.","journal-title":"Eur J Intern Med"},{"issue":"1","key":"12939_CR2","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12931-023-02650-9","volume":"25","author":"C de Diego","year":"2024","unstructured":"de Diego C, Lasierra AB, Lopez-Vergara L, Torralba L, Ruiz de Gopegui P, Lahoz R, et al. What is the actual relationship between neutrophil extracellular traps and COVID-19 severity? A longitudinal study. Respir Res. 2024;25(1):48. https:\/\/doi.org\/10.1186\/s12931-023-02650-9.","journal-title":"Respir Res"},{"issue":"9","key":"12939_CR3","doi-asserted-by":"publisher","first-page":"e2335728","DOI":"10.1001\/jamanetworkopen.2023.35728","volume":"6","author":"CN Shappell","year":"2023","unstructured":"Shappell CN, Klompas M, Chan C, Chen T, Kanjilal S, McKenna C, et al. Use of Electronic Clinical Data to Track Incidence and Mortality for SARS-CoV-2-Associated Sepsis. JAMA Netw Open. 2023;6(9):e2335728. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.35728.","journal-title":"JAMA Netw Open"},{"key":"12939_CR4","doi-asserted-by":"publisher","first-page":"120389","DOI":"10.1016\/j.biomaterials.2020.120389","volume":"267","author":"YY Lee","year":"2021","unstructured":"Lee YY, Park HH, Park W, Kim H, Jang JG, Hong KS, et al. Long-acting nanoparticulate DNase-1 for effective suppression of SARS-CoV-2-mediated neutrophil activities and cytokine storm. Biomaterials. 2021;267:120389. https:\/\/doi.org\/10.1016\/j.biomaterials.2020.120389.","journal-title":"Biomaterials"},{"issue":"5663","key":"12939_CR5","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1126\/science.1092385","volume":"303","author":"V Brinkmann","year":"2004","unstructured":"Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, et al. Neutrophil extracellular traps kill bacteria. Science. 2004;303(5663):1532\u20135. https:\/\/doi.org\/10.1126\/science.1092385.","journal-title":"Science"},{"issue":"6","key":"12939_CR6","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1248\/bpb.26.753","volume":"26","author":"S Yui","year":"2003","unstructured":"Yui S, Nakatani Y, Mikami M, Calprotectin. (S100A8\/S100A9), an inflammatory protein complex from neutrophils with a broad apoptosis-inducing activity. Biol Pharm Bull. 2003;26(6):753\u201360. https:\/\/doi.org\/10.1248\/bpb.26.753.","journal-title":"Biol Pharm Bull"},{"issue":"21","key":"12939_CR7","doi-asserted-by":"publisher","first-page":"9813","DOI":"10.1073\/pnas.0909927107","volume":"107","author":"A Hakkim","year":"2010","unstructured":"Hakkim A, Furnrohr BG, Amann K, Laube B, Abed UA, Brinkmann V, et al. Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis. Proc Natl Acad Sci U S A. 2010;107(21):9813\u20138. https:\/\/doi.org\/10.1073\/pnas.0909927107.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6367","key":"12939_CR8","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1126\/science.aam8897","volume":"358","author":"M Jimenez-Alcazar","year":"2017","unstructured":"Jimenez-Alcazar M, Rangaswamy C, Panda R, Bitterling J, Simsek YJ, Long AT, et al. Host DNases prevent vascular occlusion by neutrophil extracellular traps. Science. 2017;358(6367):1202\u20136. https:\/\/doi.org\/10.1126\/science.aam8897.","journal-title":"Science"},{"key":"12939_CR9","doi-asserted-by":"publisher","first-page":"149560","DOI":"10.1155\/2012\/149560","volume":"2012","author":"W Meng","year":"2012","unstructured":"Meng W, Paunel-Gorgulu A, Flohe S, Witte I, Schadel-Hopfner M, Windolf J, et al. Deoxyribonuclease is a potential counter regulator of aberrant neutrophil extracellular traps formation after major trauma. Mediators Inflamm. 2012;2012:149560. https:\/\/doi.org\/10.1155\/2012\/149560.","journal-title":"Mediators Inflamm"},{"key":"12939_CR10","doi-asserted-by":"publisher","first-page":"104077","DOI":"10.1016\/j.ebiom.2022.104077","volume":"80","author":"N Chapuis","year":"2022","unstructured":"Chapuis N, Ibrahimi N, Belmondo T, Goulvestre C, Berger AE, Mariaggi AA, et al. Dynamics of circulating calprotectin accurately predict the outcome of moderate COVID-19 patients. EBioMedicine. 2022;80:104077. https:\/\/doi.org\/10.1016\/j.ebiom.2022.104077.","journal-title":"EBioMedicine"},{"issue":"1","key":"12939_CR11","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s40560-024-00740-4","volume":"12","author":"I Didriksson","year":"2024","unstructured":"Didriksson I, Lengquist M, Spangfors M, Leffler M, Sievert T, Lilja G, et al. Increasing plasma calprotectin (S100A8\/A9) is associated with 12-month mortality and unfavourable functional outcome in critically ill COVID-19 patients. J Intensive Care. 2024;12(1):26. https:\/\/doi.org\/10.1186\/s40560-024-00740-4.","journal-title":"J Intensive Care"},{"issue":"10","key":"12939_CR12","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1021\/acsinfecdis.3c00249","volume":"9","author":"L Mellett","year":"2023","unstructured":"Mellett L, Amarasinghe G, Farnsworth CW, Khader SA. Elevated Level of Circulating but Not Urine S100A8\/A9 Identifies Poor COVID-19 Outcomes. ACS Infect Dis. 2023;9(10):1815\u201320. https:\/\/doi.org\/10.1021\/acsinfecdis.3c00249.","journal-title":"ACS Infect Dis"},{"issue":"3","key":"12939_CR13","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1515\/cclm-2022-1165","volume":"61","author":"L Nevejan","year":"2023","unstructured":"Nevejan L, Strypens T, Van Nieuwenhove M, Boel A, Cattoir L, Van Vaerenbergh K, et al. Serial measurement of circulating calprotectin as a prognostic biomarker in COVID-19 patients in intensive care setting. Clin Chem Lab Med. 2023;61(3):494\u2013502. https:\/\/doi.org\/10.1515\/cclm-2022-1165.","journal-title":"Clin Chem Lab Med"},{"issue":"1","key":"12939_CR14","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/JLB.3COVCRA0720-359R","volume":"109","author":"H Shi","year":"2021","unstructured":"Shi H, Zuo Y, Yalavarthi S, Gockman K, Zuo M, Madison JA, et al. Neutrophil calprotectin identifies severe pulmonary disease in COVID-19. J Leukoc Biol. 2021;109(1):67\u201372. https:\/\/doi.org\/10.1002\/JLB.3COVCRA0720-359R.","journal-title":"J Leukoc Biol"},{"issue":"5","key":"12939_CR15","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1111\/joim.13549","volume":"292","author":"M Tr\u00f8seid","year":"2022","unstructured":"Tr\u00f8seid M, Dahl TB, Holter JC, Kildal AB, Murphy SL, Yang K, et al. Persistent T-cell exhaustion in relation to prolonged pulmonary pathology and death after severe COVID-19: Results from two Norwegian cohort studies. J Intern Med. 2022;292(5):816\u201328. https:\/\/doi.org\/10.1111\/joim.13549.","journal-title":"J Intern Med"},{"issue":"21","key":"12939_CR16","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1001\/jama.2009.1754","volume":"302","author":"JL Vincent","year":"2009","unstructured":"Vincent JL, Rello R, Marshall J, Silva E, Anzueto A, Martin CD, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009;302(21):2323\u20139. https:\/\/doi.org\/10.1001\/jama.2009.1754.","journal-title":"JAMA"},{"issue":"1","key":"12939_CR17","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3390\/jmp3010004","volume":"3","author":"MK Fagerhol","year":"2022","unstructured":"Fagerhol MK, Rugtveit J. Heterogeneity of Fecal Calprotectin Reflecting Generation of Neutrophil Extracellular Traps (NETs) in the Gut: New Immunoassays Are Available. J Mol Pathol. 2022;3(1):38\u201351. https:\/\/doi.org\/10.3390\/jmp3010004.","journal-title":"J Mol Pathol"},{"issue":"1","key":"12939_CR18","doi-asserted-by":"publisher","first-page":"e13274","DOI":"10.1111\/sji.13274","volume":"98","author":"MK Fagerhol","year":"2023","unstructured":"Fagerhol MK, Schultz NH, Mirlashari MR, Wiedmann MKH, Nissen-Meyer LSH, Soraas AVL, et al. DNase analysed by a novel competitive assay in patients with complications after ChAdOx1 nCoV-19 vaccination and in normal unvaccinated blood donors. Scand J Immunol. 2023;98(1):e13274. https:\/\/doi.org\/10.1111\/sji.13274.","journal-title":"Scand J Immunol"},{"issue":"23","key":"12939_CR19","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1001\/jama.2012.5669","volume":"307","author":"VM Ranieri","year":"2012","unstructured":"ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307(23):2526\u201333. https:\/\/doi.org\/10.1001\/jama.2012.5669.","journal-title":"JAMA"},{"issue":"8","key":"12939_CR20","doi-asserted-by":"publisher","first-page":"e0290242","DOI":"10.1371\/journal.pone.0290242","volume":"18","author":"J Charostad","year":"2023","unstructured":"Charostad J, Rezaei Zadeh Rukerd M, Shahrokhi A, Aghda FA, Ghelmani Y, Pourzand P, et al. Evaluation of hematological parameters alterations in different waves of COVID-19 pandemic: A cross-sectional study. PLoS ONE. 2023;18(8):e0290242. https:\/\/doi.org\/10.1371\/journal.pone.0290242.","journal-title":"PLoS ONE"},{"issue":"8","key":"12939_CR21","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436","volume":"384","author":"P Horby","year":"2021","unstructured":"RECOVERY Collaborative Group, Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, et al. Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2021;384(8):693\u2013704. https:\/\/doi.org\/10.1056\/NEJMoa2021436.","journal-title":"N Engl J Med"},{"issue":"1","key":"12939_CR22","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1186\/s12879-023-08653-7","volume":"23","author":"N Abu Hussein","year":"2023","unstructured":"Abu Hussein N, Machahua C, Ruchti SC, Horn MP, Piquilloud L, Prella M, et al. Circulating calprotectin levels four months after severe and non-severe COVID-19. BMC Infect Dis. 2023;23(1):650. https:\/\/doi.org\/10.1186\/s12879-023-08653-7.","journal-title":"BMC Infect Dis"},{"key":"12939_CR23","doi-asserted-by":"publisher","unstructured":"Martens C, Kraisin S, Vel\u00e1squez Pereira L, Lavend\u2019homme R, Jacobs C, Vanderbeke L, et al. Decreased DNase activity in severe COVID-19 correlates with increased circulating NET burden [abstract]. ISTH; 2022; London. https:\/\/doi.org\/10.1002\/rth2.12787.","DOI":"10.1002\/rth2.12787"},{"issue":"1","key":"12939_CR24","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12931-023-02336-2","volume":"24","author":"FP Veras","year":"2023","unstructured":"Veras FP, Gomes GF, Silva BMS, Caetite DB, Almeida C, Silva CMS, et al. Targeting neutrophils extracellular traps (NETs) reduces multiple organ injury in a COVID-19 mouse model. Respir Res. 2023;24(1):66. https:\/\/doi.org\/10.1186\/s12931-023-02336-2.","journal-title":"Respir Res"},{"issue":"2","key":"12939_CR25","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1097\/SHK.0000000000000396","volume":"44","author":"SH Mai","year":"2015","unstructured":"Mai SH, Khan M, Dwivedi DJ, Ross CA, Zhou J, Gould TJ, et al. Delayed but not Early Treatment with DNase Reduces Organ Damage and Improves Outcome in a Murine Model of Sepsis. Shock. 2015;44(2):166\u201372. https:\/\/doi.org\/10.1097\/SHK.0000000000000396.","journal-title":"Shock"},{"issue":"1","key":"12939_CR26","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/joim.13783","volume":"296","author":"A Barratt-Due","year":"2024","unstructured":"Barratt-Due A, Pettersen K, Borresdatter-Dahl T, Holter JC, Gronli RH, Dyrhol-Riise AM, et al. Escalated complement activation during hospitalization is associated with higher risk of 60-day mortality in SARS-CoV-2-infected patients. J Intern Med. 2024;296(1):80\u201392. https:\/\/doi.org\/10.1111\/joim.13783.","journal-title":"J Intern Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-12939-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12939-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12939-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T13:01:18Z","timestamp":1775566878000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-12939-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,2]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12939"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-12939-x","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,2]]},"assertion":[{"value":"21 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research was carried out in accordance with the Helsinki declaration. All participants gave written informed consent, either directly or through a legally authorized representative, to participate in this study. The study was approved by the Regional Committee for Medical and Health Research Ethics in South-Eastern Norway (reference no 106624).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"723"}}